INJECTPOWER

InjectPower, founded in 2020, specializes in developing ultra-miniature, solid-state microbatteries for implantable medical devices. The company addresses the challenge of battery size in active implantable devices, allowing for greater miniaturization and enhanced functionality. Its microbatteries are the smallest in the world, featuring high energy density and a lifespan exceeding ten years, thanks to advanced all-solid lithium-ion thin-film technology. With over one million units produced, InjectPower's microbatteries support applications such as continuous intraocular pressure monitoring, intracranial pressure measurement, and electrical stimulation for chronic disease management. These batteries enable devices to operate autonomously for weeks with minimal recharging, facilitating continuous data collection and patient monitoring. InjectPower collaborates with partners like CEA-Leti and Injectsense and has secured €8.7 million in funding to establish a dedicated production facility for its innovative microbatteries.

• Employees 5
• Founded 2020
• Total Funding $7000000